RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Cito Capital Group, LLC's Holding History (CIK: 0001722439)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 52,000 Value ($000) $0 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 80,000 Value ($000) $1 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 80,000 Value ($000) $1 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 77,000 Value ($000) $1 Avg Close $8.72 Range $6.75 - $10.66